Federal contract award
75F40122P00020
PM AND REPAIR SERVICE CONTRACT ON RANDOX RX DAYTONA PLUS CHEMISTRY ANALYZER, SERIAL NUMBER: 7241-0551
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 811219 |
| PSC | J066 — Maintenance, Repair and Rebuilding of Equipment: Instruments and Laboratory Equipment |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $43.4K |
| Current contract value | $43.4K |
| Potential contract value / ceiling | $43.4K |
| Start date | Dec 29, 2021 |
| Current end date | Dec 28, 2025 |
| Potential end date | Dec 28, 2025 |
| Latest award activity | Jul 13, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 13, 2026 | P00005 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS AND CLOSEOUT THE CONTRACT. |
| Nov 22, 2024 | P00004 | $11.3K | PM AND REPAIR SERVICE CONTRACT ON RANDOX RX DAYTONA PLUS CHEMISTRY ANALYZER, SERIAL NUMBER: 7241-0551 |
| Dec 29, 2023 | P00003 | $11.0K | PM AND REPAIR SERVICE CONTRACT ON RANDOX RX DAYTONA PLUS CHEMISTRY ANALYZER, SERIAL NUMBER: 7241-0551 |
| Oct 24, 2022 | P00002 | $10.7K | PM AND REPAIR SERVICE CONTRACT ON RANDOX RX DAYTONA PLUS CHEMISTRY ANALYZER, SERIAL NUMBER: 7241-0551 |
| Mar 21, 2022 | P00001 | $0 | MODIFICATION TO INCORPORATE IPP CLAUSE |
| Dec 28, 2021 | 0 | $10.4K | PM AND REPAIR SERVICE CONTRACT ON RANDOX RX DAYTONA PLUS CHEMISTRY ANALYZER, SERIAL NUMBER: 7241-0551 |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Suzanne Martella | Contact | suzanne.martella@fda.hhs.gov 8705437540 | Source | Dec 3, 2021 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.